BDBM572005 2-(((alphaR)-6-(2,5- dioxo-4-(N- benzyloxycarbonyl- piperidin-4- ylmethyl)imidazolidin- 1- yl)spiro[3.3]heptan- 2- yl)oxy)nicotinamide::US11447487, Example 98

SMILES NC(=O)c1cccnc1O[C@H]1CC2(C1)C[C@H](N1C(=O)NC(CC3CCN(C(=O)OCc4ccccc4)CC3)C1=O)C2

InChI Key InChIKey=ZFVGFADTFMFLMV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 572005   

TargetRho-associated protein kinase 2(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 572005BDBM572005(2-(((alphaR)-6-(2,5- dioxo-4-(N- benzyloxycarbonyl...)
Affinity DataIC50: 52nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent